BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

535 related articles for article (PubMed ID: 36661246)

  • 21. Pioglitazone can improve liver sex hormone-binding globulin levels and lipid metabolism in polycystic ovary syndrome by regulating hepatocyte nuclear factor-4α.
    Zhao H; Wang D; Xing C; Lv B; Wang X; He B
    J Steroid Biochem Mol Biol; 2023 May; 229():106265. PubMed ID: 36737028
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Network pharmacology integrated with experimental validation reveals the regulatory mechanism of action of Hehuan Yin decoction in polycystic ovary syndrome with insulin resistance.
    Wu YY; Li SY; Zhu HQ; Zhuang ZM; Shao M; Chen FL; Liu CS; Tang QF
    J Ethnopharmacol; 2022 May; 289():115057. PubMed ID: 35121050
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protective effects of berberine in a rat model of polycystic ovary syndrome mediated via the PI3K/AKT pathway.
    Yu J; Ding C; Hua Z; Jiang X; Wang C
    J Obstet Gynaecol Res; 2021 May; 47(5):1789-1803. PubMed ID: 33709493
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Humanin Alleviates Insulin Resistance in Polycystic Ovary Syndrome: A Human and Rat Model-Based Study.
    Wang Y; Zeng Z; Zhao S; Tang L; Yan J; Li N; Zou L; Fan X; Xu C; Huang J; Xia W; Zhu C; Rao M
    Endocrinology; 2021 Aug; 162(8):. PubMed ID: 33693742
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Up-regulation of miR-133a-3p promotes ovary insulin resistance on granulosa cells of obese PCOS patients via inhibiting PI3K/AKT signaling.
    Yang X; Wang K; Lang J; Guo D; Gao H; Qiu Y; Jin X; Zhang M; Shi J; Ma Q; Ma Q; Wen Z
    BMC Womens Health; 2022 Oct; 22(1):412. PubMed ID: 36209087
    [TBL] [Abstract][Full Text] [Related]  

  • 26. microRNA-103 Contributes to Progression of Polycystic Ovary Syndrome Through Modulating the IRS1/PI3K/AKT Signal Axis.
    Mu J; Yu P; Li Q
    Arch Med Res; 2021 Jul; 52(5):494-504. PubMed ID: 33583602
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Berberine decreases insulin resistance in a PCOS rats by improving GLUT4: Dual regulation of the PI3K/AKT and MAPK pathways.
    Zhang N; Liu X; Zhuang L; Liu X; Zhao H; Shan Y; Liu Z; Li F; Wang Y; Fang J
    Regul Toxicol Pharmacol; 2020 Feb; 110():104544. PubMed ID: 31778716
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The ameliorating effects of Guizhi Fuling Wan combined with rosiglitazone in a rat ovarian model of polycystic ovary syndrome by the PI3K/AKT/NF-κB and Nrf2/HO-1 pathways.
    Ye Y; Zhou W; Ren Y; Lu J; Chen A; Jin R; Xuan F
    Gynecol Endocrinol; 2023 Dec; 39(1):2254848. PubMed ID: 37706434
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ameliorative effect of sesame oil on experimentally induced polycystic ovary syndrome: A cross-link between XBP-1/PPAR-1, regulatory proteins for lipogenesis/steroids.
    Elshamy AM; Shatat D; AbuoHashish NA; Safa MAE; Elgharbawy N; Ibrahim HA; Barhoma RAE; Eltabaa EF; Ahmed AS; Shalaby AM; Alabiad MA; Alorini M; Ibrahim RR
    Cell Biochem Funct; 2023 Mar; 41(2):268-279. PubMed ID: 36810739
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Luteolin alleviates polycystic ovary syndrome in rats by resolving insulin resistance and oxidative stress.
    Huang Y; Zhang X
    Am J Physiol Endocrinol Metab; 2021 Jun; 320(6):E1085-E1092. PubMed ID: 33900851
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Electroacupuncture ameliorates hepatic defects in a rat model of polycystic ovary syndrome induced by letrozole and a high-fat diet.
    Huang S; Yu C; Hu M; Wen Q; Wen X; Li S; Li K; Ma H
    Acupunct Med; 2024 Apr; 42(2):87-99. PubMed ID: 38044823
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The interactions of CAP and LYN with the insulin signaling transducer CBL play an important role in polycystic ovary syndrome.
    Shen H; Xu X; Fu Z; Xu C; Wang Y
    Metabolism; 2022 Jun; 131():155164. PubMed ID: 35217034
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cangfudaotan Decoction Alleviates Insulin Resistance and Improves Follicular Development in Rats with Polycystic Ovary Syndrome via IGF-1-PI3K/Akt-Bax/Bcl-2 Pathway.
    Wang C; Ding C; Hua Z; Chen C; Yu J
    Mediators Inflamm; 2020; 2020():8865647. PubMed ID: 33299379
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Letrozole Rat Model Mimics Human Polycystic Ovarian Syndrome and Changes in Insulin Signal Pathways.
    Xu J; Dun J; Yang J; Zhang J; Lin Q; Huang M; Ji F; Huang L; You X; Lin Y
    Med Sci Monit; 2020 Jul; 26():e923073. PubMed ID: 32638705
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spirulina versus metformin for controlling some insulin signaling pathway genes in induced polycystic ovary syndrome rat model.
    El Leithy AA; Abozaid M; Al-Karmalawy AA; Mahmoud Allam R; Nourelden AZ; Amer RM; Abd El Azeem NH; Abo-Zeid FS
    Gene; 2024 Aug; 921():148524. PubMed ID: 38735598
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The efficacy and mechanism of Angelica sinensis (Oliv.) Diels root aqueous extract based on RNA sequencing and 16S rDNA sequencing in alleviating polycystic ovary syndrome.
    Gao Y; Mo S; Cao H; Zhi Y; Ma X; Huang Z; Li B; Wu J; Zhang K; Jin L
    Phytomedicine; 2023 Nov; 120():155013. PubMed ID: 37639812
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SGLT-2 inhibitors enhance the effect of metformin to ameliorate hormonal changes and inflammatory markers in a rat PCOS model.
    Mahmoud MM; Rashed LA; Soliman SA; Sayed SM; Kamel O; Kamar SS; Hussien RES
    Physiol Rep; 2023 Nov; 11(22):e15858. PubMed ID: 37985173
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metformin Ameliorates Uterine Defects in a Rat Model of Polycystic Ovary Syndrome.
    Zhang Y; Hu M; Meng F; Sun X; Xu H; Zhang J; Cui P; Morina N; Li X; Li W; Wu XK; Brännström M; Shao R; Billig H
    EBioMedicine; 2017 Apr; 18():157-170. PubMed ID: 28336389
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Follicular Fluid-Derived Exosomal MicroRNA-18b-5p Regulates PTEN-Mediated PI3K/Akt/mTOR Signaling Pathway to Inhibit Polycystic Ovary Syndrome Development.
    Zhou Z; Tu Z; Zhang J; Tan C; Shen X; Wan B; Li Y; Wang A; Zhao L; Hu J; Ma N; Zhou J; Chen L; Song Y; Lu W
    Mol Neurobiol; 2022 Apr; 59(4):2520-2531. PubMed ID: 35092573
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of sitagliptin combined with rosiglitazone on autophagy and inflammation in polycystic ovary syndrome by regulating PI3K/AKT/mTOR and TLR4/NF-κB pathway.
    Ren Y; Ye Y; Xuan F; Chen A; Jin R; Zhou W; Lu J
    Reprod Biol; 2023 Jun; 23(2):100763. PubMed ID: 37075562
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.